Browsing by Author "Greco, F. A."
Now showing items 1-6 of 6
-
Article
Cancer of unknown primary during pregnancy: An exceptionally rare coexistence
Pavlidis, Nicholas; Peccatori, Fedro A.; Lofts, F.; Greco, F. A. (2015)Background: Cancer in pregnancy is a rare disease with breast cancer, cervical cancer, melanoma and Hodgkin's disease to be the most commonly diagnosed malignancies during gestation. Cancer of unknown primary (CUP) is a ...
-
Article
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fizazi, K.; Greco, F. A.; Pavlidis, Nicholas; Daugaard, G.; Oien, K.; Pentheroudakis, George; ESMO Guidelines Committee (2015)
-
Article
Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Fizazi, K.; Greco, F. A.; Pavlidis, Nicholas; Pentheroudakis, George (2011)
-
Article
Diagnostic and therapeutic management of cancer of an unknown primary
Pavlidis, Nicholas; Briassoulis, E. Ch; Hainsworth, J.; Greco, F. A. (2003)Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3% of all malignant neoplasms and is therefore one of the 10 most frequent cancer diagnoses in man. Patients with CUP present with metastatic disease ...
-
Article
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review
Pentheroudakis, George; Greco, F. A.; Pavlidis, Nicholas (2009)Background: Gene expression profiling platforms were recently shown to accurately assign cancer of unknown primary (CUP) to a primary tissue of origin, with unknown impact on patient outcome. We examined chemotherapy ...
-
Article
Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors
Greco, F. A.; Pavlidis, Nicholas (2009)The treatment for patients with unknown primary carcinoma, particularly those with unfavorable prognosis factors, has changed in the last decade, and continues to evolve. Empiric chemotherapy trials reported since 2000 ...